Yankton Kevin Bruce 4
4 · Twist Bioscience Corp · Filed Dec 22, 2022
Insider Transaction Report
Form 4
Yankton Kevin Bruce
Chief Accounting Officer
Transactions
- Award
Common Stock
[F1]2022-09-30+1,500→ 10,428 total - Tax Payment
Common Stock
[F2]2022-12-20$35.24/sh−220$7,753→ 10,208 total
Footnotes (2)
- [F1]Award of Performance Stock Units ("PSUs"). 1/2 of the PSUs have vested on September 30, 2022 ("Achievement Date"). The remaining half will vest on the one year anniversary of the Achievement Date subject to Mr. Yankton's continuous service.
- [F2]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person referenced in Footnote 1. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
Signature
/s/ Alyssa Zhang, Attorney-in-Fact for Kevin B. Yankton|2022-12-22